Blood Transfusion Diagnostics Market Size, Share, Development, Growth and Demand Forecast to 2027

Global Blood Transfusion Diagnostics Market   – Overview

Blood transfusion is an essential part of providing healthcare services to the patients. Blood and blood products like RBC’s, WBC’s, platelets and others are transfused from one person to another. This requires screening tests which are vital before conducting blood transfusion. Strict regulation governing the use and transfer of blood, increasing awareness regarding blood transfusion and automation of blood banks drive the growth of this market. Furthermore, increasing demand for diagnostic and treatment devices in developed and developing countries further influence the growth of the market. However, the growth of the market is restrained by various factors such as risk involved in transmission of infectious disease from one person to another without carrying out screening procedure.

Get Sample report at .

Global Blood Transfusion Diagnostics Market   – Competitive Analysis

There is a significant increase in the number of the company offering blood transfusion diagnostics. Some major companies are trying to focus on new and advanced tests & products to gain the market. Whereas, some are has used the technique of acquisition and collaboration to gain the market.

Hoffmann-La Roche AG:

  • August, 2015: F. Hoffmann-La Roche AG acquired GeneWEAVE to strengthen offerings in microbiology diagnostics. Roche will pay GeneWEAVE shareholders USD 190 million upfront and up to USD 235 million in contingent product related milestones
  • February 2015 : F. Hoffmann-La Roche AG announced the collaboration with BioMed X for the development of Nanomaterial-Based Biosensors for Near-Patient Testing
  • September 2014: F. Hoffmann-La Roche AG launched Elecsys anti-Müllerian Hormone (AMH) fertility test for assessment of ovarian reserve for pregnancy


  • June, 2017: Alere shareholders approve amended merger with Abbott. This merger will further strengthen the global presence of the company.
  • August, 2016: Abbott announced the introduction of its new “Alinity”, a family of next generation systems across immunoassay, clinical chemistry, point of care, haematology, blood and plasma screening and molecular diagnostics.
  • April, 2016: The company received FDA approval for its companion diagnostics “Vysis CLL FISH probe kit” in Leukemia. The kit is used to detect the 17p deletion in chronic lymphocytic leukemia patients, the target population of a new drug from AbbVie.
  • April, 2016: Abbott received FDA approval for its companion diagnostics “Vysis CLL FISH probe kit” in Leukemia. The kit is used to detect the 17p deletion in chronic lymphocytic leukemia patients, the target population of a new drug from AbbVie.

Bio-Rad Laboratories, Inc.:

July 2017: Bio-Rad Laboratories, Inc., a global provider of life science research and clinical diagnostic products launched Amplichek I quality control for the testing of infectious diseases.

Key Players
The key players that are involved in global blood transfusion diagnostics market are Immucor (U.S), Ortho Clinical Diagnostics (U.S), Beckman Coulter (U.S), Quotient Limited (U.S), Diagast (France), Abbott Diagnostics (U.S), Novartis AG (Switzerland), Becton Dickinson (U.S), BAG healthcare (Germany) DiaSorin (Italy), Fujirebio (Belgium), Grifols (Spain), Siemens (Germany), Quidel (U.S), Hologic/Gen-Probe (U.S), Biokit (Spain), Bio-Rad (U.S).

Global Blood Transfusion Diagnostics Market   – Regional Analysis

Globally, Americas account for the largest market share in blood transfusion diagnostics market consists of two regions namely North America and South America. Increasing in number of blood banks, adoption of automation in blood banks, awareness programs in school & medical institutes and demand of safe and reliable technology for blood transfusion drive this market in North America. Increasing adoption of Nucleic Acid Amplification for diagnosis of blood and blood products also contribute to the growth of this market in North America. United States is the biggest market place worldwide contributing 46% of total blood transfusion diagnostics market. Ortho-Clinical Diagnostic is the largest transfusion diagnostic equipment and solution provider with estimated market share of 7 to 8%. Medical institutes conduct lecture and conference on safe blood transfusion for medical students and also for patients. Europe blood transfusion diagnostics market has observed stable growth owing to increasing demand for advanced diagnostic products. Asia-Pacific is fastest growing market region for this market due to presence of huge patient pool, and huge opportunity for the market growth. The Middle East and Africa holds the least share in the market due to lack of awareness among the people and limited development of medical sector.

The market for Blood Transfusion Diagnostics is segmented into mainly three; by type, by application and by End users and its various sub-segments. By type include Instruments, Reagents, Others. Whereas by application it includes Blood Grouping, disease Screening, others. Furthermore by end users include Hospital, laboratories, Blood Banks, Plasma Fractionation Facilities, Military Blood Banks and others.

Get Discount on report at .

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Designed by
Powered by